drugset / Trial / NCT00918476

Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)

NCT00918476

Phase 1 Completed 14 enrolled Pfizer
CrossoverOpen-label

Summary

The purpose of this study is to estimate the effect of filibuvir on the pharmacokinetics of ethinyloestradiol \[EE\] and levonorgestrel \[LN\], to assess the safety and tolerability of 600 mg BID of filibuvir in healthy women and to investigate the pharmacokinetics of 600 mg BID of filibuvir in healthy women.

Timeline

Start
2010-06
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Filibuvir Small molecule 600 mg Oral
Subject Levonorgestrel Small molecule Oral
Subject ethinyl estradiol Small molecule Oral